NCT06733077Recruiting
Development of Digital Services for Parkinson's Disease
Development of Digital Diagnostics and Intervention Services for Parkinson's Disease
Source: ClinicalTrials.gov · Last updated 3 Feb 2025 · Not updated for over 12 months - ask the site whether it is still open
Brief summary (registry, in English)
In this project, ocular motor, pupil and gait data in people with Parkinson's disease (PD) will be collected in order to develop machine learning models for the diagnosis and monitoring of PD. With this, the investigators aim to advance the state of the art in PD diagnosis and monitoring. By integrating the principles of machine learning with high-quality sensor data, more accurate and earlier diagnosis could potentially be achieved. Ocular motor and pupil data will be collected with the standard clinical examination and with neos, a medical device approved for objective ocular motor and pupil measurement. Gait will be collected using an IMU sensor and GaitQ senti, a consumer device that allows for an objective and continuous remote gait monitoring.
- Status (registry)
- Recruiting
- Study type
- Interventional
- Enrollment
- 80 (estimated)
- First submitted
- 20 Nov 2024
- Start date
- 20 Dec 2024
- Primary completion date
- 1 Apr 2026
- Lead sponsor
- University of Exeter
- Diseases
- Parkinson disease
- NCT number
- NCT06733077
What you commit to
- Study type: Interventional
- Planned participants: 80
- From 20 Dec 2024 to the primary completion date, 1 Apr 2026
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Deep brain stimulation or pacemaker implants or other implant that may interfere with the measurement system
- Medications likely to affect eye sight or use of virtual reality sytstem
- Healthy participants
- Deep brain stimulation or pacemaker implants or other implants that may interfere with the measurement system
Other illness
- Any physical or mental condition affecting ability to safely participate in this level of activity and capacity to understand testing as demonstrated by ability to safely follow commands and pass the PARQ by the research team.
- Cognitive impairment affecting ability to safely participate and follow instructions
- Any injury or disorder that may affect balance (other than Parkinson's or referring primary condition)
- Any skin conditions or broken skin in the calf and behind knee area
- Any physical or mental condition affecting ability to safely participate in this level of activity and capacity to understand testing as demonstrated by ability to safely follow commands and pass the PARQ by the research team.
- Cognitive impairment affecting ability to safely participate and follow instructions
- Any injury or disorder that may affect balance (other than Parkinson's or referring primary condition)
- Any skin conditions or broken skin in the calf and behind knee area
Who the study is looking for
- Diagnosis of idiopathic Parkinson's disease (UK Brain Bank Criteria) or other appropriate condition specific scale \[stroke, multiple sclerosis, arthritis or osteoporosis\]
- Able to self-report history of daily gait freezing and/or festination for people with PD or gait and/or transfers affected by condition
- Able to walk unsupported or using an aid for at least 5 minutes and satisfactory completion of the Canadian PARQ and if over 69 used to carrying out this level of exercise
- Adult (+18 years old)
- Normal or corrected-to-normal vision (Snellen Visual Acuity \> 12/18) or safe to mobilise with support
- Montreal Cognitive assessment score \>21 or ability to follow 2 stage commands
- Healthy participants \[Phase 1,2,3\]
- With no long-term conditions affecting movement
- Able to walk unsupported or using an aid for at least 3 minutes and satisfactory completion of the Canadian PARQ and if over 69 used to carrying out this level of exercise
- Adult (+18 years old)
- Normal or corrected-to-normal vision (Snellen Visual Acuity \> 12/18) or safe to mobilise with support
- Montreal Cognitive assessment score \>21 or ability to follow 2 stage commands
Age in the registry: 18 years to - · Sex: All · Accepts healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| University Of Exeter Coordinator of this site? Confirm its status | Exeter | United Kingdom | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.